- Previous Close
0.155 - Open
0.154 - Bid 0.150 x --
- Ask 0.153 x --
- Day's Range
0.148 - 0.160 - 52 Week Range
0.148 - 0.290 - Volume
571,540 - Avg. Volume
824,781 - Market Cap (intraday)
278.797M - Beta (5Y Monthly) -0.19
- PE Ratio (TTM)
-- - EPS (TTM)
-0.010 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trade of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the research, development, and commercialization of oral insulin products; distribution of bio-industrial products; healthcare management; and provision of genetic testing services, as well as securities investment. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
www.ipb.asiaRecent News: 0399.HK
View MorePerformance Overview: 0399.HK
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0399.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0399.HK
View MoreValuation Measures
Market Cap
282.44M
Enterprise Value
1.13B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
87.85
Price/Book (mrq)
--
Enterprise Value/Revenue
191.96
Enterprise Value/EBITDA
5.39
Financial Highlights
Profitability and Income Statement
Profit Margin
194.33%
Return on Assets (ttm)
-0.65%
Return on Equity (ttm)
1.76%
Revenue (ttm)
5.89M
Net Income Avi to Common (ttm)
11.46M
Diluted EPS (ttm)
-0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
428k
Total Debt/Equity (mrq)
189.99%
Levered Free Cash Flow (ttm)
-128.15M